Development of a Mass Spectrometry-Based Method for Quantification of Ustekinumab in Serum Specimens.
Ther Drug Monit
; 42(4): 572-577, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-31985551
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Serum
/
Tandem Mass Spectrometry
/
Ustekinumab
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Ther Drug Monit
Year:
2020
Type:
Article
Affiliation country:
Germany